Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of soquelitinib in patients with T cell lymphoma will ...

Apparently Companies House have so far issued 1.5 million ID codes.  They expect to ID 7 million directors altogether.

Internal Zilliz benchmarks show that purpose-built Milvus outperforms PostgreSQL with pgvector, delivering 60% lower latency and 4.5 times higher throughput under identical vector search conditions.

Oracle’s rapid OCI cloud and AI growth signal a high-upside phase. Discover projected 27% gains and market drivers.